Concepedia

Xiangling Xiao

XX

Statistics

Publications

17

Citations

773

H-Index

14

Active since

2016

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Guangdong Polytechnic Normal University

Harvard University

Institute of Biomedical Sciences, Academia Sinica

Xiangling Xiao is an author at Zhongnan Hospital of Wuhan University specializing in oncology, medicine, and immunotherapy.

ORCID

Publications per year

2016–2025

17

Publications

17

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

Wenjun Xiong, Xueliang Gao, Tiantian Zhang et al. · Nature Communications · 2022 · 150 citations · Full text

, , +17

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy

H. Li, Yishuang Sun, Yingmeng Yao et al. · Proceedings of the National Academy of Sciences · 2024 · 122 citations · Full text

, , +8

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy

Haisheng Yu, Jing Liu, Xia Bu et al. · Cell chemical biology · 2023 · 89 citations · Full text

, , +17

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Xiangling Xiao, Jie Shi, Chuan He et al. · Nature Communications · 2023 · 77 citations · Full text

, , +17

Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways

Xiangling Xiao, Zhongwei He, Wei Cao et al. · International Journal of Oncology · 2016 · 63 citations · Full text

, , +14

1–5 of 17